Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.915 USD | +0.98% |
|
+0.63% | -59.12% |
Jul. 01 | Vor Biopharma Inc.(NasdaqGS:VOR) dropped from Russell 3000E Value Index | CI |
Jul. 01 | Vor Biopharma Inc.(NasdaqGS:VOR) dropped from Russell 2000 Value Index | CI |
Business Summary
Number of employees: 168
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bob Ang
CEO | Chief Executive Officer | 49 | 19-08-06 |
Chief Tech/Sci/R&D Officer | 51 | 20-10-31 | |
Eyal Attar
CTO | Chief Tech/Sci/R&D Officer | 53 | 22-10-11 |
Sarah Spencer
IRC | Investor Relations Contact | - | - |
Tania Philipp
HRO | Human Resources Officer | 52 | 19-11-30 |
John C. King
PRN | Corporate Officer/Principal | 49 | 20-07-31 |
General Counsel | 76 | 20-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 20-07-29 |
Matt Patterson
CHM | Chairman | 52 | 20-10-19 |
Bob Ang
CEO | Chief Executive Officer | 49 | 19-08-06 |
Bill Lundberg
BRD | Director/Board Member | 60 | 19-02-28 |
Daniella Beckman
BRD | Director/Board Member | 45 | 20-07-15 |
Joshua Resnick
BRD | Director/Board Member | 49 | 19-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 68,269,901 | 67,439,940 ( 98.78 %) | 0 | 98.78 % |
Company contact information
![address Vor Biopharma Inc.(VOR)](https://cdn.zonebourse.com/static/address/118621680.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.12% | 61.85M | |
+17.52% | 44.63B | |
+43.51% | 40.46B | |
-9.12% | 38.07B | |
+33.19% | 32.27B | |
-8.98% | 27.3B | |
+14.60% | 26.53B | |
+45.29% | 14.06B | |
+32.54% | 12.54B | |
-8.52% | 11.28B |
- Stock Market
- Equities
- VOR Stock
- Company Vor Biopharma Inc.